共 50 条
Metabolite-Based Modification of Poly(L-lysine) for Improved Gene Delivery
被引:18
|作者:
Urello, Morgan A.
[1
]
Xiang, Lucia
[1
]
Colombo, Raffaele
[1
]
Ma, Alexander
[2
]
Joseph, Augustine
[2
]
Boyd, Jonathan
[1
]
Peterson, Norman
[3
]
Gao, Changshou
[1
]
Wu, Herren
[1
]
Christie, R. James
[1
]
机构:
[1] AstraZeneca, Antibody Discovery & Prot Engn R&D, Gaithersburg, MD 20878 USA
[2] SynChem Inc, Elk Grove Village, IL 60007 USA
[3] AstraZeneca Biopharmaceut R&D, Translat Sci, Gaithersburg, MD 20878 USA
关键词:
POLYPLEX MICELLES;
LINEAR POLYETHYLENIMINE;
ACID;
TRANSFECTION;
PROTONATION;
CATIOMERS;
PATHWAYS;
POLYMER;
D O I:
10.1021/acs.biomac.0c00614
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Synthetic gene delivery systems employ multiple functions to enable safe and effective transport of DNA to target cells. Here, we describe metabolite-based poly(L-lysine) (PLL) modifiers that improve transfection by imparting both pH buffering and nanoparticle stabilization functions within a single molecular unit. PLL modifiers were based on morpholine (M), morpholine and niacin (MN), or thiomorpholine (TM). PLL modification with (MN) or (TM) imparted buffering function over the pH range of 57 both in solution and live cells and enhanced the stability of PLL DNA nanoparticles, which exhibited higher resistance to polyanion exchange and prolonged blood circulation. These properties translated into increased transfection efficiency in vitro coupled with reduced toxicity compared to unmodified PLL and PLL(M). Furthermore, PEG-PLL(MN) DNA nanoparticles transfected muscle tissue in vivo for >45 days following intramuscular injection. These polymer modifiers demonstrate the successful design of multifunctional units that improve transfection of synthetic gene delivery systems while maintaining biocompatibility.
引用
收藏
页码:3596 / 3607
页数:12
相关论文